Results 251 to 260 of about 1,080,358 (387)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Pro-C-Type Natriuretic Peptide in Women With Angina Pectoris and No Obstructive Coronary Artery Disease. [PDF]

open access: yesJACC Adv
Mark PD   +5 more
europepmc   +1 more source

Atrial Natriuretic Peptide Infusion in Chronic Heart Failure in the Rat

open access: bronze, 1989
Masahiro Kohzuki   +4 more
openalex   +1 more source

Atrial natriuretic peptide concentrations in pre-eclampsia:: Authors' reply [PDF]

open access: green, 1987
J. K. Thomsen   +4 more
openalex   +1 more source

The effect of different water temperatures on the release of the atrial natriuretic factor (ANF) during "head out water immersion (HOI)" [PDF]

open access: yes, 1991
Arendt, Rainer M.   +5 more
core   +1 more source

Effects of atrial natriuretic peptide on renal function and renin release in the isolated perfused rat kidney.

open access: bronze, 1987
Shosaku Narumi   +6 more
openalex   +2 more sources

Cis-Active Determinants of Cardiac-Specific Expression in the Human Atrial Natriuretic Peptide Gene [PDF]

open access: bronze, 1991
Jiangping Wu   +4 more
openalex   +1 more source

Prognostic utility of advanced lung cancer inflammation index in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
The advanced lung cancer inflammation index (ALI) is an integrated marker of inflammation and nutritional status, calculated by body mass index × serum albumin / neutrophil‐to‐lymphocyte ratio. Low ALI levels were significantly associated with poor prognosis in elderly multimorbid HFpEF patients.
Daisuke Sakamoto   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy